State Street’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

State Street’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,442	Closed	-$43K	–	4588
2023 Q3	$43K	Hold	14,442	–	–	﹤0.01%	4320
2023 Q2	$35.1K	Hold	14,442	–	–	﹤0.01%	4503
2023 Q1	$24.6K	Buy	+14,442	New	+$32.7K	﹤0.01%	4650
2022 Q4	–	Sell	-2,242	Closed	-$13K	–	4965
2022 Q3	$13K	Hold	2,242	–	–	﹤0.01%	4877
2022 Q2	$35K	Hold	2,242	–	–	﹤0.01%	4799
2022 Q1	$43K	Buy	2,242 +72	+3%	+$1.2K	﹤0.01%	4821
2021 Q4	$41K	Hold	2,170	–	–	﹤0.01%	4731
2021 Q3	$99K	Hold	2,170	–	–	﹤0.01%	4553
2021 Q2	$132K	Buy	+2,170	New	+$152K	﹤0.01%	4312

State Street's TMBR Position: Q4 2023 in Review

State Street sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2023, closing a stake of 14,442 shares — an estimated $43K sold.

State Street first reported a position in TMBR in Q2 2021 and held it in 9 quarters. The position peaked at $132K in Q2 2021. 0 funds tracked by Wall St. Rank hold TMBR as of Q4 2023.

State Street reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
State Street sold 14,442 Timber Pharmaceuticals, Inc. shares in Q4 2023, an estimated $43K.
State Street first reported a position in Timber Pharmaceuticals, Inc. in Q2 2021 and held it in 9 quarters.
State Street's Timber Pharmaceuticals, Inc. position peaked at $132K in Q2 2021.
0 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.